Impax Laboratories and Tolmar have entered a multi-product agreement for the development, supply and distribution of alternative dosage form products. The products and terms were not disclosed. “We are excited to expand our relationship with Tolmar on these products. It represents an ideal extension of our initial product agreement,” said Larry Hsu, Ph.D., president and chief executive officer of Impax Laboratories. “In the past two years, we have entered into four distinct partnerships for alt...